Profilo

PD Dr. Wildhaber joined BioMedPartners in January 2007.
Previously, she was a Managing Director for the Novartis Venture Fund where she served on the boards of Athelas, NanoPowers, CellnTec and Oncalis.
She has more than 19 years of experience in pharmaceutical R&D and business development.
In Novartis, she was Head of Immunology Project Management, Immunology Research, Oncology Business Development and Licensing as well as a member of the Corporate Mergers and Acquisition team.
Prior to joining Novartis, Dr. Wildhaber performed postdoctoral research on tumor virology (FMI-Basel), membrane proteins and lipids (ETH-Zurich) and monoclonal antibodies and crystallisation of bacterial photosynthetic proteins (MPI-Munich).
Her qualifications include a Biochemistry B.Sc.
(UK), Ph.D (performed at Max Planck Institute for Immunology, Freiburg) and PD (Privatdozentin) from the ETH-Zurich.

Precedenti posizioni note di Frances Wildhaber

SocietàPosizioneFine
Investitore di Private Equity 01/03/2009
Direttore degli Investimenti 01/01/2007
Vedi nel dettaglio l'esperienza di Frances Wildhaber

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Frances Wildhaber

Relazioni

2

Relazioni di 1° grado

2

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private2

Finance

Finance

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Frances Wildhaber
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA